EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Coeptis Therapeutics Holdings, Inc. (COEP) had EBIT Margin of -956.94% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$1.36M |
|
$-11.92M |
|
$0.18M |
|
$1.18M |
|
$14.41M |
|
$-13.04M |
|
$0.77M |
|
$-12.28M |
|
$-12.11M |
|
$-12.28M |
|
$-12.28M |
|
$-12.28M |
|
$-12.11M |
|
$-13.04M |
|
$-11.32M |
|
4.23M |
|
4.23M |
|
$-2.81 |
|
$-2.81 |
|
| Balance Sheet Financials | |
$7.35M |
|
$0.01M |
|
$8.80M |
|
$16.15M |
|
$1.77M |
|
$0.15M |
|
$0.32M |
|
$2.09M |
|
$14.07M |
|
$13.71M |
|
$14.07M |
|
5.75M |
|
| Cash Flow Statement Financials | |
$-8.60M |
|
$0.00M |
|
$13.74M |
|
$0.53M |
|
$5.67M |
|
$5.14M |
|
$5.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.16 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
86.75% |
|
-956.94% |
|
|
EBIT Margin |
-956.94% |
-830.25% |
|
-900.72% |
|
-874.29% |
|
$-8.60M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
185.50 |
|
1.97 |
|
-87.27% |
|
-89.57% |
|
-76.00% |
|
-86.35% |
|
$2.45 |
|
$-2.03 |
|
$-2.03 |
|